{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:59:15Z","timestamp":1738666755168,"version":"3.36.0"},"reference-count":19,"publisher":"Scientific Foundation Spiroski (publications)","issue":"1","license":[{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Open Access Maced J Med Sci"],"abstract":"<jats:p>AIM: The purpose of this study is to see the effect of Dexketoprofen on TNF-\u00ce\u00b1, IL-1, and IL-6 serum levels in Chronic Tension-Type Headache (CTTH) patients and its correlation with pain severity.METHOD: The study subjects were recruited consecutively from the study population. Venous blood was taken at baseline to measure serum levels of TNF-\u00ce\u00b1, IL-1, and IL-6 and after ten consecutive days of Dexketoprofen 25 mg once daily.RESULTS: Twenty three subjects participated in this study, 3 male (13.0%) and 20 female (87%). A significant difference between NRS score at baseline and after treatment (4.86 \u00c2\u00b1 1.82 vs. 1.96 \u00c2\u00b1 1.40, p = 0.001) was found. No significant difference found between baseline and after treatment TNF-\u00ce\u00b1 (1.48 \u00c2\u00b1 0.65 pg\/dl vs. 1.48 \u00c2\u00b1 0.63 pg\/dl, p = 0.963), IL-1 (0.16 \u00c2\u00b1 0.80 pg\/dl vs. 0.26 \u00c2\u00b1 0.31 pg\/dl, p = 0.168) nor IL-6 serum levels (1.06 \u00c2\u00b1 0.83 pg\/dl vs. 1.04 \u00c2\u00b1 0.81 pg\/dl, p = 0.915). A weak negative (R = -0.266) non significant correlation (p = 0.219) was found between NRS score and TNF-\u00ce\u00b1. A positive weak negative (R = 0.221) non significant correlation (p = 0.311) between NRS score and IL-1. NRS score and IL-6 had a negative very weak (R = -0.019) non significant negative correlation (p = 0.931).CONCLUSIONS: Dexketoprofen decreased pain intensity significantly (p = 0.001), but had no effect on TNF-\u00ce\u00b1 IL-1 nor IL-6 serum levels. NRS score had a weak and non significant negative correlation with TNF-\u00ce\u00b1, a weak and non significant positive correlation with IL-1, and a very weak and non significant negative correlation with IL-6 serum levels.<\/jats:p>","DOI":"10.3889\/oamjms.2017.024","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T12:17:46Z","timestamp":1486469866000},"page":"54-57","source":"Crossref","is-referenced-by-count":6,"title":["Tumour Necrosis Factor-\u00ce\u2018, Interleukin-1 and Interleukin-6 Serum Levels and Its Correlation with Pain Severity in Chronic Tension-Type Headache Patients: Analysing Effect of Dexketoprofen Administration"],"prefix":"10.3889","volume":"5","author":[{"given":"Aldy Safruddin","family":"Rambe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Sjahrir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moh Hasan","family":"Machfoed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"52292","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"29002","doi-asserted-by":"crossref","unstructured":"Bendtsen L, Jensen R. Tension-Type Headache. Neurol Clin. 2009;27: 525\u00e2\u20ac\u201c535. https:\/\/doi.org\/10.1016\/j.ncl.2008.11.010 PMid:19289230","DOI":"10.1016\/j.ncl.2008.11.010"},{"key":"29003","doi-asserted-by":"crossref","unstructured":"Stovner LJ, Hagen K, Jensen R, Katsavara Z, Lipton RB, Scher A, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27:193\u00e2\u20ac\u201c210. https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01288.x PMid:17381554","DOI":"10.1111\/j.1468-2982.2007.01288.x"},{"key":"29004","doi-asserted-by":"crossref","unstructured":"Bo SH, Davidsen EM, Gulbrandsen P, et al. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia. 2008;29(3): 365-372. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01727.x PMid:19175774","DOI":"10.1111\/j.1468-2982.2008.01727.x"},{"key":"29005","doi-asserted-by":"crossref","unstructured":"Ko\u00c3\u00a7er A, Memi\u00c5\u0178o\u00c4\u0178ullari R, Doma\u00c3\u00a7 FM, Ilhan A, Ko\u00c3\u00a7er E, Okuyucu S, et al. IL-6 levels in migraine patients receiving topiramate. Pain Pract. 2010;9: 375\u00e2\u20ac\u201c379. https:\/\/doi.org\/10.1111\/j.1533-2500.2009.00301.x PMid:19622115","DOI":"10.1111\/j.1533-2500.2009.00301.x"},{"key":"29006","doi-asserted-by":"crossref","unstructured":"Backonja MJ, Coe CL, Muller DA, Schell K. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. Journal of Neuroimmunology. 2008;195(1-2):157-163. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.01.005 PMid:18325600","DOI":"10.1016\/j.jneuroim.2008.01.005"},{"key":"29007","doi-asserted-by":"crossref","unstructured":"Vedova CD, Cathcart S, Dohnalek A, Lee V, Hutchinson MR, Immink MA, et al. Peripheral interleukin-1\u00ce\u00b2 levels are elevated in chronic tension-type headache patients. Pain Res Manag. 2013;18:301-306. https:\/\/doi.org\/10.1155\/2013\/796161 PMid:23957020 PMCid:PMC3917793","DOI":"10.1155\/2013\/796161"},{"key":"29008","doi-asserted-by":"crossref","unstructured":"Barbanoj MJ, Antonijoan RM, Gich I. Clinical pharmacokinetics of dexketoprofen. Clinical Pharmacokinet. 2011; 40(4): 245-262. https:\/\/doi.org\/10.2165\/00003088-200140040-00002 PMid:11368291","DOI":"10.2165\/00003088-200140040-00002"},{"key":"29009","doi-asserted-by":"crossref","unstructured":"Barden J, Derry S, McQuay HJ, Moore RA. Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;(4):CD007355. https:\/\/doi.org\/10.1002\/14651858.cd007355.pub2","DOI":"10.1002\/14651858.CD007355.pub2"},{"key":"29010","doi-asserted-by":"crossref","unstructured":"Tanure MTA, Gomez RS, Hurtado RCL, Teixera AL, Domingues RB. Increased serum levels of brain-derived neurotropic factorduring migraine attacks: a pilot study. J Headache Pain. 2010;11:427\u00e2\u20ac\u201c430. https:\/\/doi.org\/10.1007\/s10194-010-0233-0 PMid:20556464 PMCid:PMC3452273","DOI":"10.1007\/s10194-010-0233-0"},{"key":"29011","doi-asserted-by":"crossref","unstructured":"Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. European Journal of Pharmacology. 1997;340(2\u00e2\u20ac\u201c3): 249\u00e2\u20ac\u201c258. https:\/\/doi.org\/10.1016\/S0014-2999(97)01393-9","DOI":"10.1016\/S0014-2999(97)01393-9"},{"key":"29012","unstructured":"Rozen D. Treatment of tension-type headache with botox: a review of the literature. Mt Sinai J Med. 2010; 73: 493-98."},{"key":"29013","unstructured":"Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 6th ed. Saunders Elsevier, 2007."},{"key":"29014","doi-asserted-by":"crossref","unstructured":"Punke MA, Friederich P. Dexketoprofen is a potent blocker of human Kv1.1 and Kv7.2\/7.3 channels\". Anesthesia and Analgesia. 2007;104 (5): 1256\u00e2\u20ac\u201c1264. https:\/\/doi.org\/10.1213\/01.ane.0000260310.63117.a2 PMid:17456683","DOI":"10.1213\/01.ane.0000260310.63117.a2"},{"key":"29015","unstructured":"Quan N, Herkenham M. Connecting cytokines and brain: A review of current issues. Histol Histopatho. 2002;17: 273-288. PMid:11813877"},{"key":"29016","unstructured":"Durham ZL, Durham PL. Interleukins IL-1B and IL-S Cause Sensitization of Trigeminal GanglionNeurons Leading to Changes in the Ganglion and Trigeminal Nucleus Caudalis Implications for Understanding their Role in Migraine Pathology. National Headache Foundation's 7th Headache Research Summit, 2009."},{"key":"29017","doi-asserted-by":"crossref","unstructured":"Contassot E, Beer HD, French LE. Interleukin-1, Inflammasomes, autoinflammation and the skin. Swiss Med Wkly. 2012;142:w13590. https:\/\/doi.org\/10.4414\/smw.2012.13590","DOI":"10.4414\/smw.2012.13590"},{"key":"29018","doi-asserted-by":"crossref","unstructured":"D'Elia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC. Targetting the \"Cytokine Storm\" for Therapeutic Benefit. Clinical and Vaccine Immunology. 2013; 20(3):319-327. https:\/\/doi.org\/10.1128\/CVI.00636-12 PMid:23283640 PMCid:PMC3592351","DOI":"10.1128\/CVI.00636-12"},{"key":"29019","doi-asserted-by":"crossref","unstructured":"Yan J, Melemedjian OK, Price TJ, Dusson G. Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Molecular Pain. 2012;8(6): 1-9. https:\/\/doi.org\/10.1186\/1744-8069-8-6","DOI":"10.1186\/1744-8069-8-6"},{"key":"29020","doi-asserted-by":"crossref","unstructured":"Neeb L, Hellen P, Boehnke C, Hoffmann J, Schuh-Hofer S, Dirnagl U, et al. IL-1b Stimulates COX-2 Dependent PGE2 Synthesis and CGRP Release in Rat Trigeminal Ganglia Cells. PLoS ONE 6(3). 2011: e17360. https:\/\/doi.org\/10.1371\/journal.pone.0017360 PMid:21394197 PMCid:PMC3048859","DOI":"10.1371\/journal.pone.0017360"}],"container-title":["Open Access Macedonian Journal of Medical Sciences"],"original-title":[],"link":[{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2017.024\/1268","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2017.024\/1306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T22:34:43Z","timestamp":1622414083000},"score":1,"resource":{"primary":{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/view\/oamjms.2017.024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,2,15]]}},"URL":"https:\/\/doi.org\/10.3889\/oamjms.2017.024","relation":{},"ISSN":["1857-9655"],"issn-type":[{"type":"electronic","value":"1857-9655"}],"subject":[],"published":{"date-parts":[[2017,2,6]]}}}